-
1
-
-
42549108748
-
Acinetobacter bau-mannii: Epidemiology, antimicrobial resistance, and treatment options
-
Maragakis LL, Perl TM: Acinetobacter bau-mannii: Epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008; 46:1254-1263
-
(2008)
Clin Infect Dis
, vol.46
, pp. 1254-1263
-
-
Maragakis, L.L.1
Perl, T.M.2
-
2
-
-
58149240183
-
Carbapenem-resistant Enterobacteriaceae: A potential threat
-
Schwaber MJ, Carmeli Y: Carbapenem-resistant Enterobacteriaceae: A potential threat. JAMA 2008; 300(24):2911-2913
-
(2008)
JAMA
, vol.300
, Issue.24
, pp. 2911-2913
-
-
Schwaber, M.J.1
Carmeli, Y.2
-
3
-
-
0035871033
-
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneu-moniae: Risk factors for infection and impact of resistance on outcomes
-
Lautenbach E, Patel JB, Bilker WB, et al: Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneu-moniae: Risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32:1162-1171
-
(2001)
Clin Infect Dis
, vol.32
, pp. 1162-1171
-
-
Lautenbach, E.1
Patel, J.B.2
Bilker, W.B.3
-
4
-
-
22144433025
-
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-produc-ing Enterobacteriaceae: Variability by site of infection
-
Hyle EP, Lipworth AD, Zaoutis TE, et al: Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-produc-ing Enterobacteriaceae: Variability by site of infection. Arch Intern Med 2005; 165: 1375-1380
-
(2005)
Arch Intern Med
, vol.165
, pp. 1375-1380
-
-
Hyle, E.P.1
Lipworth, A.D.2
Zaoutis, T.E.3
-
5
-
-
30144434179
-
Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: Maximizing clinical outcomes and minimizing selection of resistant organisms
-
Niederman MS: Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: Maximizing clinical outcomes and minimizing selection of resistant organisms. Clin Infect Dis 2006; 42(Suppl 2):S72-S81
-
(2006)
Clin Infect Dis
, vol.42
, Issue.SUPPL. 2
-
-
Niederman, M.S.1
-
6
-
-
25444451566
-
Et al Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: The role of inadequate empirical antimicrobial therapy
-
Lautenbach E, Metlay JP, Bilker WB, et al Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: The role of inadequate empirical antimicrobial therapy. Clin Infect Dis 2005; 41:923-929
-
(2005)
Clin Infect Dis
, vol.41
, pp. 923-929
-
-
Lautenbach, E.1
Metlay, J.P.2
Bilker, W.B.3
-
7
-
-
0037185447
-
Health and economic outcomes of the emergence of third-generation cephalospo-rin resistance in Enterobacter species
-
Cosgrove SE, Kaye KS, Eliopoulous GM, et al: Health and economic outcomes of the emergence of third-generation cephalospo-rin resistance in Enterobacter species. Arch Intern Med 2002; 162:185-190
-
(2002)
Arch Intern Med
, vol.162
, pp. 185-190
-
-
Cosgrove, S.E.1
Kaye, K.S.2
Eliopoulous, G.M.3
-
8
-
-
0033599982
-
Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa
-
Carmeli Y, Troillet N, Karchmer AW, et al: Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 1999; 159:1127-1132
-
(1999)
Arch Intern Med
, vol.159
, pp. 1127-1132
-
-
Carmeli, Y.1
Troillet, N.2
Karchmer, A.W.3
-
9
-
-
33747362870
-
Colistin: The re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
-
Li J, Nation RL, Turnidge JD, et al: Colistin: The re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 2006; 6:589-601
-
(2006)
Lancet Infect Dis
, vol.6
, pp. 589-601
-
-
Li, J.1
Nation, R.L.2
Turnidge, J.D.3
-
10
-
-
36448983944
-
Poly-myxin B for the treatment of multidrug-resistant pathogens: A critical review
-
Zavascki AP, Goldani LZ, Li J, et al: Poly-myxin B for the treatment of multidrug-resistant pathogens: A critical review. J An-timicrob Chemother 2007; 60:1206-1215
-
(2007)
J An-timicrob Chemother
, vol.60
, pp. 1206-1215
-
-
Zavascki, A.P.1
Goldani, L.Z.2
Li, J.3
-
11
-
-
29944446141
-
Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact
-
Aloush V, Navon-Venezia S, Seigman-Igra Y, et al: Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact. Antimicrob Agents Chemother 2006; 50: 43-48
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 43-48
-
-
Aloush, V.1
Navon-Venezia, S.2
Seigman-Igra, Y.3
-
12
-
-
33646912478
-
Fluoroquinolone-resistant Pseudomonas aeruginosa: Assessment of risk factors and clinical impact
-
Gasink LB, Fishman NO, Weiner MG, et al: Fluoroquinolone-resistant Pseudomonas aeruginosa: Assessment of risk factors and clinical impact. Am J Med 2006; 119: 526-1525
-
(2006)
Am J Med
, vol.119
, pp. 526-1525
-
-
Gasink, L.B.1
Fishman, N.O.2
Weiner, M.G.3
-
13
-
-
33749028483
-
Imipenem resistance among Pseudomo-nas aeruginosa isolates: Risk factors for infection and impact of resistance on clinical and economic outcomes
-
Lautenbach E, Weiner MG, Nachamkin I, et al: Imipenem resistance among Pseudomo-nas aeruginosa isolates: Risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol 2006; 27:893-900
-
(2006)
Infect Control Hosp Epidemiol
, vol.27
, pp. 893-900
-
-
Lautenbach, E.1
Weiner, M.G.2
Nachamkin, I.3
-
14
-
-
33846116186
-
Multidrug-resistant Acinetobacter infection mortality rate and length of hospital-ization
-
Sunenshine RH, Wright MO, Maragakis LL, et al: Multidrug-resistant Acinetobacter infection mortality rate and length of hospital-ization. Emerg Infect Dis 2007; 13:97-103
-
(2007)
Emerg Infect Dis
, vol.13
, pp. 97-103
-
-
Sunenshine, R.H.1
Wright, M.O.2
Maragakis, L.L.3
-
15
-
-
34248208644
-
Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia
-
Kwon KT, Oh WS, Song JH, et al: Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimi-crob Chemother 2007; 59:525-530
-
(2007)
J Antimi-crob Chemother
, vol.59
, pp. 525-530
-
-
Kwon, K.T.1
Oh, W.S.2
Song, J.H.3
-
16
-
-
35348890215
-
Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes
-
Abbo A, Carmeli Y, Navon-Venezia S, et al: Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis 2007; 26:793-800
-
(2007)
Eur J Clin Microbiol Infect Dis
, vol.26
, pp. 793-800
-
-
Abbo, A.1
Carmeli, Y.2
Navon-Venezia, S.3
-
17
-
-
33144460009
-
The epidemiology and control of Acinetobacter baumannii in health care facilities
-
Fournier PE, Richet H: The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006; 42:692-699
-
(2006)
Clin Infect Dis
, vol.42
, pp. 692-699
-
-
Fournier, P.E.1
Richet, H.2
-
18
-
-
19944421444
-
Predictors of mortality in Acinetobacter baumannii bacteremia
-
Chen HP, Chen TL, Lai CH, et al: Predictors of mortality in Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 2005; 38:127-136
-
(2005)
J Microbiol Immunol Infect
, vol.38
, pp. 127-136
-
-
Chen, H.P.1
Chen, T.L.2
Lai, C.H.3
-
19
-
-
0037352118
-
Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: A matched cohort study
-
Blot S, Vandewoude K, Colardyn F: Nosoco-mial bacteremia involving Acinetobacter baumannii in critically ill patients: A matched cohort study. Intensive Care Med 2003; 29:471-475 (Pubitemid 36379452)
-
(2003)
Intensive Care Medicine
, vol.29
, Issue.3
, pp. 471-475
-
-
Blot, S.1
Vandewoude, K.2
Colardyn, F.3
-
20
-
-
73449096797
-
Risk factors and clinical impact of Kleb-siella pneumoniae carbapenemase-produc-ing K. pneumoniae
-
Gasink LB, Edelstein PH, Lautenbach E, et al: Risk factors and clinical impact of Kleb-siella pneumoniae carbapenemase-produc-ing K. pneumoniae. Infect Control Hosp Epidemiol 2009; 30:1180-1185
-
(2009)
Infect Control Hosp Epidemiol
, vol.30
, pp. 1180-1185
-
-
Gasink, L.B.1
Edelstein, P.H.2
Lautenbach, E.3
-
21
-
-
62749131175
-
Centers for Disease Control and Prevention: Guidance for control of infections with car-bapenem-resistant or carbapenemase-pro-ducing Enterobacteriaceae in acute care facilities
-
Centers for Disease Control and Prevention: Guidance for control of infections with car-bapenem-resistant or carbapenemase-pro-ducing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009; 58:256-260
-
(2009)
MMWR Morb Mortal Wkly Rep
, vol.58
, pp. 256-260
-
-
-
22
-
-
72249087115
-
International study of the prevalence and outcomes of infection in intensive care units
-
Vincent JL, Rello J, Marshall J, et al: International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302:2323-2329
-
(2009)
JAMA
, vol.302
, pp. 2323-2329
-
-
Vincent, J.L.1
Rello, J.2
Marshall, J.3
-
23
-
-
71449094486
-
National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 2008, issued December 2009
-
Edwards JR, Peterson KD, Mu Y, et al: National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009; 37:783-805
-
(2009)
Am J Infect Control
, vol.37
, pp. 783-805
-
-
Edwards, J.R.1
Peterson, K.D.2
Mu, Y.3
-
24
-
-
54949148412
-
NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007
-
Hidron AI, Edwards JR, Patel J, et al: NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29:996-1011
-
(2008)
Infect Control Hosp Epidemiol
, vol.29
, pp. 996-1011
-
-
Hidron, A.I.1
Edwards, J.R.2
Patel, J.3
-
25
-
-
77951034298
-
Multidrug resistance among Gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008
-
Kallen AJ, Hidron AI, Patel J, et al: Multidrug resistance among Gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol 2010; 31:528-531
-
(2010)
Infect Control Hosp Epidemiol
, vol.31
, pp. 528-531
-
-
Kallen, A.J.1
Hidron, A.I.2
Patel, J.3
-
26
-
-
33747604662
-
What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?
-
Harris AD, McGregor JC, Furuno JP: What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? Clin Infect Dis 2006; 43(Suppl 2):S57-S61
-
(2006)
Clin Infect Dis
, vol.43
, Issue.SUPPL. 2
-
-
Harris, A.D.1
McGregor, J.C.2
Furuno, J.P.3
-
27
-
-
77951251859
-
Treatment with fluoroquinolones or with beta-lactam/beta-lactamase inhibitor combinations are risk factors for the isolation of extended-spectrum {beta}-lactamase-producing Klebsiella species in hospitalized patients
-
Wener KM, Schechner V, Gold HS, et al: Treatment with fluoroquinolones or with beta-lactam/beta-lactamase inhibitor combinations are risk factors for the isolation of extended-spectrum {beta}-lactamase-producing Klebsiella species in hospitalized patients. Antimicrob Agents Chemother. 2010; 54(5):2010-2016
-
(2010)
Antimicrob Agents Chemother.
, Issue.5
, pp. 2010-2016
-
-
Wener, K.M.1
Schechner, V.2
Gold, H.S.3
-
28
-
-
9144232354
-
International prospective study of Klebsiella pneumoniae bacteremia: Implications of extended-spectrum beta-lactamase production in nosocomial Infections
-
Paterson DL, Ko WC, Von Gottberg A, et al: International prospective study of Klebsiella pneumoniae bacteremia: Implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med 2004; 140:26-32
-
(2004)
Ann Intern Med
, vol.140
, pp. 26-32
-
-
Paterson, D.L.1
Ko, W.C.2
Von Gottberg, A.3
-
29
-
-
0142252609
-
Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: A case-control study in a district teaching hospital in Taiwan
-
Lin MF, Huang ML, Lai SH: Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: A case-control study in a district teaching hospital in Taiwan. J Hosp Infect 2003; 53:39-45
-
(2003)
J Hosp Infect
, vol.53
, pp. 39-45
-
-
Lin, M.F.1
Huang, M.L.2
Lai, S.H.3
-
30
-
-
0033979735
-
Outbreak of a multiresistant Klebsiella pneu-moniae strain in an intensive care unit: Antibiotic use as risk factor for colonization and infection
-
Asensio A, Oliver A, Gonzalez-Diego P, et al: Outbreak of a multiresistant Klebsiella pneu-moniae strain in an intensive care unit: Antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000; 30:55-60
-
(2000)
Clin Infect Dis
, vol.30
, pp. 55-60
-
-
Asensio, A.1
Oliver, A.2
Gonzalez-Diego, P.3
-
31
-
-
33847027647
-
Carbap-enem-resistant Acinetobacter baumannii in intensive care unit patients: Risk factors for acquisition, infection and their consequences
-
Playford EG, Craig JC, Iredell JR: Carbap-enem-resistant Acinetobacter baumannii in intensive care unit patients: Risk factors for acquisition, infection and their consequences. J Hosp Infect 2007; 65:204-211
-
(2007)
J Hosp Infect
, vol.65
, pp. 204-211
-
-
Playford, E.G.1
Craig, J.C.2
Iredell, J.R.3
-
32
-
-
67651085441
-
Carbapenem resistance among Klebsiella pneumoniae isolates: Risk factors, molecular characteristics, and susceptibility patterns
-
Hussein K, Sprecher H, Mashiach T, et al: Carbapenem resistance among Klebsiella pneumoniae isolates: Risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009; 30: 666-671
-
(2009)
Infect Control Hosp Epidemiol
, vol.30
, pp. 666-671
-
-
Hussein, K.1
Sprecher, H.2
Mashiach, T.3
-
33
-
-
0037097507
-
Control-group selection importance in studies of antimicrobial resistance: Examples applied to Pseudomonas aeruginosa, entero-cocci, and Escherichia coli
-
Harris AD, Samore MH, Lipsitch M, et al: Control-group selection importance in studies of antimicrobial resistance: Examples applied to Pseudomonas aeruginosa, entero-cocci, and Escherichia coli. Clin Infect Dis 2002; 34:1558-1563
-
(2002)
Clin Infect Dis
, vol.34
, pp. 1558-1563
-
-
Harris, A.D.1
Samore, M.H.2
Lipsitch, M.3
-
34
-
-
13644269309
-
And Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
-
American Thoracic Society
-
American Thoracic Society and Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
-
(2005)
Am J Respir Crit Care Med
, vol.171
, pp. 388-416
-
-
-
35
-
-
77954649852
-
Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission
-
Nseir S, Grailles G, Soury-Lavergne A, et al: Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission. Clin Microbiol Infect 2010; 16:902-908
-
(2010)
Clin Microbiol Infect
, vol.16
, pp. 902-908
-
-
Nseir, S.1
Grailles, G.2
Soury-Lavergne, A.3
-
36
-
-
0003457567
-
2009 Performance Standards for Antimicrobial Susceptibility Testing
-
Clinical and Laboratory Standards Institute Wayne, PA, Clinical and Laboratory Standards Institute
-
Clinical and Laboratory Standards Institute: 2009 Performance Standards for Antimicrobial Susceptibility Testing. 19th Information Supplement (M100-S19). Wayne, PA, Clinical and Laboratory Standards Institute, 2009
-
(2009)
19th Information Supplement (M100-S19)
-
-
-
38
-
-
77249160678
-
Systematic review of studies on compliance with hand hygiene guidelines in hospital care
-
Erasmus V, Daha TJ, Brug H, et al: Systematic review of studies on compliance with hand hygiene guidelines in hospital care. Infect Control Hosp Epidemiol 2010; 31:283-294
-
(2010)
Infect Control Hosp Epidemiol
, vol.31
, pp. 283-294
-
-
Erasmus, V.1
Daha, T.J.2
Brug, H.3
-
39
-
-
10844280035
-
An outbreak of multidrug-resistant Acineto-bacter baumannii associated with pulsatile lavage wound treatment
-
Maragakis LL, Cosgrove SE, Song X, et al: An outbreak of multidrug-resistant Acineto-bacter baumannii associated with pulsatile lavage wound treatment. JAMA 2004; 292: 3006-3011
-
(2004)
JAMA
, vol.292
, pp. 3006-3011
-
-
Maragakis, L.L.1
Cosgrove, S.E.2
Song, X.3
-
40
-
-
0036479514
-
Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units
-
Das I, Lambert P, Hill D, et al: Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect 2002; 50:110-114
-
(2002)
J Hosp Infect
, vol.50
, pp. 110-114
-
-
Das, I.1
Lambert, P.2
Hill, D.3
-
41
-
-
33747656337
-
Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation
-
Wilks M, Wilson A, Warwick S, et al: Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation. Infect Control Hosp Epidemiol 2006; 27:654-658
-
(2006)
Infect Control Hosp Epidemiol
, vol.27
, pp. 654-658
-
-
Wilks, M.1
Wilson, A.2
Warwick, S.3
-
42
-
-
77949556977
-
Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectant
-
Doidge M, Allworth AM, Woods M, et al: Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectant. Infect Control Hosp Epidemiol 2010; 31:418-420
-
(2010)
Infect Control Hosp Epidemiol
, vol.31
, pp. 418-420
-
-
Doidge, M.1
Allworth, A.M.2
Woods, M.3
-
43
-
-
0031808598
-
Survival of Acinetobacter baumannii on dry surfaces: Comparison of outbreak and sporadic isolates
-
Jawad A, Seifert H, Snelling AM, et al: Survival of Acinetobacter baumannii on dry surfaces: Comparison of outbreak and sporadic isolates. J Clin Microbiol 1998; 36:1938-1941
-
(1998)
J Clin Microbiol
, vol.36
, pp. 1938-1941
-
-
Jawad, A.1
Seifert, H.2
Snelling, A.M.3
-
45
-
-
0037448354
-
An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes
-
Srinivasan A, Wolfenden LL, Song X, et al: An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med 2003; 348:221-227
-
(2003)
N Engl J Med
, vol.348
, pp. 221-227
-
-
Srinivasan, A.1
Wolfenden, L.L.2
Song, X.3
-
47
-
-
0037083034
-
Nosoco-mial antibiotic resistance in multiple Gram-negative species: Experience at one hospital with squeezing the resistance balloon at multiple sites
-
Rahal JJ, Urban C, Segal-Maurer S: Nosoco-mial antibiotic resistance in multiple Gram-negative species: Experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis 2002; 34: 499-503
-
(2002)
Clin Infect Dis
, vol.34
, pp. 499-503
-
-
Rahal, J.J.1
Urban, C.2
Segal-Maurer, S.3
-
48
-
-
70049084153
-
Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting
-
Gottesman BS, Carmeli Y, Shitrit P, et al: Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin Infect Dis 2009; 49:869-875
-
(2009)
Clin Infect Dis
, vol.49
, pp. 869-875
-
-
Gottesman, B.S.1
Carmeli, Y.2
Shitrit, P.3
-
49
-
-
44649173118
-
Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures
-
Maragakis LL, Tucker MG, Miller RG, et al: Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures. JAMA 2008; 299: 2513-2514
-
(2008)
JAMA
, vol.299
, pp. 2513-2514
-
-
Maragakis, L.L.1
Tucker, M.G.2
Miller, R.G.3
-
50
-
-
77949565095
-
Natural history of colonization with Gram-negative multidrug-resistant organisms among hospitalized patients
-
Weintrob AC, Roediger MP, Barber M, et al: Natural history of colonization with Gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol 2010; 31:330-337
-
(2010)
Infect Control Hosp Epidemiol
, vol.31
, pp. 330-337
-
-
Weintrob, A.C.1
Roediger, M.P.2
Barber, M.3
-
51
-
-
57749107808
-
Bad bugs no drugs No ESKAPE! An update from the Infectious Diseases Society of America
-
Boucher HW, Talbot GH, Bradley JS, et al: Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1-12
-
(2009)
Clin Infect Dis
, vol.48
, pp. 1-12
-
-
Boucher, H.W.1
Talbot, G.H.2
Bradley, J.S.3
-
52
-
-
67749145541
-
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria
-
Plachouras D, Karvanen M, Friberg LE, et al: Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria. Antimicrob Agents Che-mother 2009; 53:3430-3436
-
(2009)
Antimicrob Agents Che-mother
, vol.53
, pp. 3430-3436
-
-
Plachouras, D.1
Karvanen, M.2
Friberg, L.E.3
-
53
-
-
67449090359
-
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: Intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
-
Roberts JA, Kirkpatrick CMJ, Roberts MS, et al: Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: Intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. J An-timicrob Chemother 2009; 64:142-150
-
(2009)
J An-timicrob Chemother
, vol.64
, pp. 142-150
-
-
Roberts, J.A.1
Cmj, K.2
Roberts, M.S.3
-
54
-
-
66449092115
-
A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics
-
Roberts JA, Webb S, Paterson D, et al: A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med 2009; 37: 2071-2078
-
(2009)
Crit Care Med
, vol.37
, pp. 2071-2078
-
-
Roberts, J.A.1
Webb, S.2
Paterson, D.3
-
55
-
-
75949106980
-
Research Committee of the Society for Healthcare Epidemiology of America: Enhancing patient safety by reducing healthcare-associated infections: The role of discovery and dissemination
-
Research Committee of the Society for Healthcare Epidemiology of America: Enhancing patient safety by reducing healthcare-associated infections: The role of discovery and dissemination. Infect Control Hosp Epidemiol 2010; 31:118-123
-
(2010)
Infect Control Hosp Epidemiol
, vol.31
, pp. 118-123
-
-
|